Iterum Therapeutics PLC (ITRM) stock news · $38.6M cap
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
This ITRM news page leads with what Iterum Therapeutics PLC filed — not a scraped headline mill.
No cached 8-K sentence for ITRM yet. We will not pad this page with generic market recap.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$9.0M. Revenue was up 954.1% from 2019-09-30 to 2025-09-30. ITRM currently screens at market cap $38.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ITRM stock page; for the tape open the quote page.
ITRM stock news FAQ
What are ITRM's latest revenue and net income?
Latest cached Iterum Therapeutics PLC (ITRM) revenue for Sep 30, 2025 was $390.0K. Net income was -$9.0M. Statements: https://lician.com/financials/itrm
How did ITRM revenue change from the prior cached period?
Cached Iterum Therapeutics PLC (ITRM) revenue was up 954.1% from $37.0K (Sep 30, 2019) to $390.0K (Sep 30, 2025). Statements: https://lician.com/financials/itrm
What is ITRM's market cap?
Iterum Therapeutics PLC (ITRM) market cap is $38.6M on the latest cached fundamentals snapshot.
What kind of company is ITRM?
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Where is ITRM stock news listed?
Cached stock news for Iterum Therapeutics PLC (ITRM) is listed at https://lician.com/news/itrm. Filings: https://lician.com/sec/itrm
Not investment advice.